Back to News
Market Impact: 0.25
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights
Source: PR Newswire
Legal & LitigationHealthcare & Biotech
DJS Law Group reminded investors of a securities class-action lawsuit against Capricor Therapeutics (NASDAQ: CAPR), alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act and SEC Rule 10b-5. The notice signals litigation risk for the biotech company, though the excerpt provides no alleged damages, class period, operational impact, or case outcome.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
CAPR-0.85
More News
- U.S. regulators rush to write crypto rulebook after Clarity Act stalls in Senate
- Heidi CEO on AI in Healthcare, $900M valuation
- Meta’s Muse AI is exploding in popularity—and already drawing heated backlash from another tech giant
- Guggenheim Names Top Stock Pick in Biotech Sector
- NYC Mayor Mamdani reaches record DoorDash settlement for underpaid workers
- Paramount Settlement Triggers WBD Breakout. How It Compares To Past Media Mergers.
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: In-App Tutorials, Futures Data, and Watchlist Enhancements
- AI Tools for Independent Research Firms: A Publishing System